February 2020 has seen a flurry of regulatory activity in India, with the ministry of health and family welfare setting out norms that expand responsibility for the quality of drugs and compliance issues beyond manufacturers.
Changes have also been proposed to the Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954, with new prison terms and...







